Slide One
HYBRID 2021 ACCESS REPLAY

DAY 1

Hybridays 2021: Frédérique VIDAL, Minister of Higher Education, Research and Innovation
Welcome from the organizers
Savita BERNAL, Chief Business Officer at MaatPharma
Pierre BELICHARD, CEO of Enterome
Nadine CERF-BENSUSSAN, Inserm, Université de Paris, Imagine Institute
Gerard EBERL, Pasteur Institute, Inserm
Anne DEJEAN, Inserm, CNRS, Toulouse III University, Toulouse Institute for Infectious and Inflammatory
Diseases (Infinity)
Public/Private Success Story
David Braga MALTA, Founding CEO of LiMM Therapeutics
René AZOULAI, CEO of Peptinov
Artificial intelligence in support of drug development for autoimmune diseases
Réjane RUA, Inserm, CNRS, Aix Marseille University, Immunology center of Marseille Luminy
Julien DIANA, Inserm, CNRS, Faculty of Paris, Necker-Enfants Malades Institute

DAY 2

Geoffrey RICHARD, Market Manager, MabDesign
Mark PEAKMAN, Head of Autoimmunity & Type-1 Diabetes Cluster, Sanofi
Jean-Jacques MENTION, Head of Scientific Business Development at Ose Immunotherapeutics
François RIEGER, CEO of Medsenic
Jean-Baptiste TELLIEZ, Senior Director - Head of In-vitro Pharmacology, Inflammation & Immunology Research Unit at Pfizer
Nicolas GAUDENZIO, Inserm, CNRS, Toulouse III University, Toulouse Institute for Infectious and
Inflammatory Diseases (Infinity)
Alexandre BELOT, Hospices civils de Lyon, Lyon I University, Inserm, CNRS, Reference Center for juvenile arthritis and rare pediatric systemic autoimmune disease, Infectious Disease National Research Center
Florence APPARAILLY, Inserm, Montpellier University, University Hospital Center of Montpellier
Howard JACOB, Vice President of Genomics Research and Head of Data Integration, Abbvie
Jean-Jacques GARAUD, CEO at Inotrem
Marc-Antoine BROCHARD, Co-founder & CEO of Stimulab
Michel DE BAAR, Executive Director, Global Development & Licensing, MSD
Olivier BOYER, Rouen University Hospital, Inserm
David DOMBROWICZ, Inserm, Pasteur Institute of Lille, Lille University, University Hospital Center of Lille
Christian DELEUZE, Chairman of the Research & Innovation Committee at LEEM